US 10793543
Selective C-KIT kinase inhibitor
granted A61KA61K31/445A61K31/45
Quick answer
US patent 10793543 (Selective C-KIT kinase inhibitor) held by HEFEI GRACEVO BIO-MEDICINE CO., LTD expires Mon Oct 01 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- HEFEI GRACEVO BIO-MEDICINE CO., LTD
- Grant date
- Tue Oct 06 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 01 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/445, A61K31/45, A61K31/454, A61K31/4545